α-Synuclein-positive structures in cases with sporadic Alzheimer’s disease: morphology and its relationship to tau aggregation

Clinical diagnosis of Alzheimer's disease: Report of the NINCDS‐ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915

Neuropathological stageing of Alzheimer-related changes.

Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123

α-Synuclein in Lewy bodies

Spillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD): Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

Mirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961

Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop

McKeith, I. G., Galasko, D., Kosaka, K., Perry, E. K., Dickson, D. W., Hansen, L. A., Salmon, D. P., Lowe, J., Mirra, S. S., Byrne, E. J., et al. (1996) · Neurology · doi:10.1212/wnl.47.5.1113 · Cited by 3,960

Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies.

(1998) · Europe PMC (PubMed Central) · Cited by 1,594

Editorial on Consensus Recommendations for the Postmortem Diagnosis of Alzheimer Disease from the National Institute on Aging and the Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer Disease

HYMAN, B. T., & TROJANOWSKI, J. Q. (1997) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199710000-00002 · Cited by 1,542

Accelerated in vitro fibril formation by a mutant α-synuclein linked to early-onset Parkinson disease

Conway, K. A., Harper, J. D., & Lansbury, P. T. (1998) · Nature Medicine · doi:10.1038/3311 · Cited by 1,520

Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease.

Uéda, K., Fukushima, H., Masliah, E., Xia, Y., Iwai, A., Yoshimoto, M., Otero, D. A., Kondo, J. D. M., Ihara, Y., & Saitoh, T. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.23.11282 · Cited by 1,502

Greenfield's Neuropathology

(1964) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1964.tb115841.x · Cited by 1,411

Conformational constraints for amyloid fibrillation: the importance of being unfolded

Uversky, V. N., & Fink, A. L. (2004) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2003.12.008 · Cited by 1,022

Neuroinflammation as a common feature of neurodegenerative disorders

Guzman-Martinez, L., Maccioni, R. B., Andrade, V., Navarrete, L. P., Pastor, M. G., & Ramos-Escobar, N. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01008 · Cited by 702

Plasma exosomal α-synuclein is likely CNS-derived and increased in Parkinson’s disease

Shi, M., Liu, C., Cook, T. J., Bullock, K. M., Zhao, Y., Ginghina, C., Li, Y., Aro, P., Dator, R., He, C., et al. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1314-y · Cited by 676

Neuropathology of sporadic Parkinson's disease: Evaluation and changes of concepts

Jellinger, K. A. (2011) · Movement Disorders · doi:10.1002/mds.23795 · Cited by 480

Colocalization of Tau and Alpha-Synuclein Epitopes in Lewy Bodies

Ishizawa, T., Mattila, P. M., Davies, P., Wang, D., & Dickson, D. W. (2003) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/62.4.389 · Cited by 402

Alpha-synuclein biology in Lewy body diseases

Kim, W. S., Kågedal, K., & Halliday, G. M. (2014) · Alzheimer s Research & Therapy · doi:10.1186/s13195-014-0073-2 · Cited by 400

α-synuclein in the pathophysiology of Alzheimer’s disease

Twohig, D., & Nielsen, H. M. (2019) · Molecular Neurodegeneration · doi:10.1186/s13024-019-0320-x · Cited by 374

Alzheimer Disease With Amygdala Lewy Bodies: A Distinct Form of α-Synucleinopathy

Uchikado, H., Lin, W.-L., DeLucia, M. W., & Dickson, D. W. (2006) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/01.jnen.0000225908.90052.07 · Cited by 359

Accumulation of Phosphorylated α-Synuclein in Aging Human Brain

Saito, Y., Kawashima, A., Ruberu, N. N., Fujiwara, H., Koyama, S., Sawabe, M., Arai, T., Nagura, H., Yamanouchi, H., Hasegawa, M., et al. (2003) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/62.6.644 · Cited by 354

Neuropathological spectrum of synucleinopathies

Jellinger, K. A. (2003) · Movement Disorders · doi:10.1002/mds.10557 · Cited by 345

Biophysics of Parkinsons Disease: Structure and Aggregation of α- Synuclein

Uversky, V. N., & Eliezer, D. (2009) · Current Protein and Peptide Science · doi:10.2174/138920309789351921 · Cited by 325

Clinicopathologic Correlations in a Large Alzheimer Disease Center Autopsy Cohort: Neuritic Plaques and Neurofibrillary Tangles "Do Count" When Staging Disease Severity

Nelson, P. T., Jicha, G. A., Schmitt, F. A., Liu, H., Davis, D. G., Mendiondo, M. S., Abner, E. L., & Markesbery, W. R. (2007) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/nen.0b013e31815c5efb · Cited by 292

α‐Synuclein contributes to GSK‐3β‐catalyzed Tau phosphorylation in Parkinson's disease models

Duka, T., Duka, V., Joyce, J. N., & Sidhu, A. (2009) · The FASEB Journal · doi:10.1096/fj.08-120410 · Cited by 276

Prevalence and impact of vascular and Alzheimer pathologies in Lewy body disease

Jellinger, K. A., & Attems, J. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0347-5 · Cited by 267

Part II: α-synuclein and its molecular pathophysiological role in neurodegenerative disease

Dev, K. K. (2003) · Neuropharmacology · doi:10.1016/s0028-3908(03)00140-0 · Cited by 267

Lewy body-related ?-synucleinopathy in the aged human brain

Jellinger, K. A. (2004) · Journal of Neural Transmission · doi:10.1007/s00702-004-0138-7 · Cited by 253

Patterns and stages of α-synucleinopathy

ZACCAI, J. H., Brayne, C., McKeith, I. G., Matthews, F. E., & Ince, P. G. (2008) · Neurology · doi:10.1212/01.wnl.0000306697.48738.b6 · Cited by 249

Intrinsic disorder in proteins associated with neurodegenerative diseases

Vladimir, N. (2009) · Frontiers in bioscience · doi:10.2741/3594 · Cited by 241

Tau Protein Interaction Partners and Their Roles in Alzheimer’s Disease and Other Tauopathies

Sinsky, J., Pichlerova, K., & Hanes, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179207 · Cited by 220

Elevated tauopathy and alpha-synuclein pathology in postmortem Parkinson's disease brains with and without dementia

Wills, J., Jones, J. M., Haggerty, T., Duka, V., Joyce, J. N., & Sidhu, A. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2010.06.017 · Cited by 217

Rapid Anionic Micelle-mediated α-Synuclein Fibrillization in Vitro

Necula, M., Chirita, C. N., & Kuret, J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m308231200 · Cited by 213

α-Synuclein pathology in Parkinson’s and Alzheimer’s disease brain: incidence and topographic distribution—a pilot study

Jellinger, K. A. (2003) · Acta Neuropathologica · doi:10.1007/s00401-003-0725-y · Cited by 201

Early-Onset Alzheimer’s Disease: What Is Missing in Research?

Ayodele, T., Rogaeva, E. A., Kurup, J. T., Beecham, G. W., & Reitz, C. (2021) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-020-01090-y · Cited by 210

Amyloidogenesis of Natively Unfolded Proteins

Uversky, V. N. (2008) · Current Alzheimer Research · doi:10.2174/156720508784533312 · Cited by 188

Confluence of α-Synuclein, Tau, and β-Amyloid Pathologies in Dementia With Lewy Bodies

Colom‐Cadena, M., Gelpí, E., Charif, S., Belbin, O., Blesa, R., Martí, M. J., Clarimón, J., & Lleó, A. (2013) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0000000000000018 · Cited by 188

Alzheimer's disease and Down's syndrome: roles of APP, trophic factors and ACh

Ole Isacson, A. (2002) · Trends in Neurosciences · doi:10.1016/s0166-2236(02)02037-4 · Cited by 187

Pathology associated with sporadic Parkinson’s disease — where does it end?

Braak, H., Müller, C. M., Rüb, U., Ackermann, H., Bratzke, H., de Vos, R. A. I., & Tredici, K. D. (2006) · Springer eBooks · doi:10.1007/978-3-211-45295-0_15 · Cited by 182

Neuropathology of multiple system atrophy: New thoughts about pathogenesis

Jellinger, K. A. (2014) · Movement Disorders · doi:10.1002/mds.26052 · Cited by 181

Late-onset vs nonmendelian early-onset Alzheimer disease

Reitz, C., Rogaeva, E. A., & Beecham, G. W. (2020) · Neurology Genetics · doi:10.1212/nxg.0000000000000512 · Cited by 184

α-Synuclein and the Lewy body disorders

Dickson, D. W. (2001) · Current Opinion in Neurology · doi:10.1097/00019052-200108000-00001 · Cited by 163

Tau and transgenic animal models

Götz, J. (2001) · Brain Research Reviews · doi:10.1016/s0165-0173(01)00055-8 · Cited by 166

Alpha-Synuclein Lesions in Normal Aging, Parkinson Disease, and Alzheimer Disease: Evidence from the Baltimore Longitudinal Study of Aging (BLSA)

Mikolaenko, I., Pletniková, O., Kawas, C. H., O’Brien, R., Resnick, S. M., Crain, B. J., & Troncoso, J. C. (2005) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/64.2.156 · Cited by 163

Identification of the region of non‐Aβ component (NAC) of Alzheimer's disease amyloid responsible for its aggregation and toxicity

Bodles, A. M., Guthrie, D. J. S., Greer, B., & Irvine, G. B. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00408.x · Cited by 149

Phosphorylation of tau and α-synuclein in synaptic-enriched fractions of the frontal cortex in Alzheimer’s disease, and in Parkinson’s disease and related α-synucleinopathies

Muntané, G., Dalfó, E., Martı́nez, A., & Ferrer, I. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.01.030 · Cited by 143

Mice expressing the A53T mutant form of human alpha‐synuclein exhibit hyperactivity and reduced anxiety‐like behavior

Graham, D. R., & Sidhu, A. (2010) · Journal of Neuroscience Research · doi:10.1002/jnr.22331 · Cited by 137

Potential Pathways of Abnormal Tau and α-Synuclein Dissemination in Sporadic Alzheimer's and Parkinson's DiseasesPreprint

Braak, H., & Tredici, K. D. (2016) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a023630 · Cited by 132

Regional Distribution of α-Synuclein Pathology in Unimpaired Aging and Alzheimer Disease

Parkkinen, L., Soininen, H. S., & Alafuzoff, I. I. (2003) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/62.4.363 · Cited by 129

Interaction between pathogenic proteins in neurodegenerative disorders

Jellinger, K. A. (2011) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2011.01507.x · Cited by 132

A postmortem study suggests a revision of the dual-hit hypothesis of Parkinson’s disease

Borghammer, P., Just, M. K., Horsager, J., Skjærbæk, C., Raunio, A., Kok, E. H., Savola, S., Murayama, S., Saito, Y., Myllykangas, L., et al. (2022) · npj Parkinson's Disease · doi:10.1038/s41531-022-00436-2 · Cited by 127

General aspects of neurodegeneration

Jellinger, K. A. (2003) · Journal of Neural Transmission. Supplementa · doi:10.1007/978-3-7091-0643-3_7 · Cited by 126

α-Synuclein modulates tau spreading in mouse brains

Bassil, F., Meymand, E. S., Brown, H. J., Xu, H. W., Cox, T. O., Pattabhiraman, S., Maghames, C. M., Wu, Q., Zhang, B., Trojanowski, J. Q., et al. (2020) · The Journal of Experimental Medicine · doi:10.1084/jem.20192193 · Cited by 109

Fatty acid incorporation is decreased in astrocytes cultured from α‐synuclein gene‐ablated mice

Castagnet, P. I., Golovko, M. Y., Barceló‐Coblijn, G., Nussbaum, R. L., & Murphy, E. J. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03247.x · Cited by 108

Alpha-synuclein: a pathological factor with Aβ and tau and biomarker in Alzheimer’s disease

Shim, K. H., Kang, M. J., Youn, Y. C., An, S. S. A., & Kim, S. (2022) · Alzheimer s Research & Therapy · doi:10.1186/s13195-022-01150-0 · Cited by 106

Functional and Pathological Effects of α-Synuclein on Synaptic SNARE Complexes

Gao, V., Briano, J. A., Komer, L. E., & Burré, J. (2022) · Journal of Molecular Biology · doi:10.1016/j.jmb.2022.167714 · Cited by 104

Developmental stages of cortical Lewy bodies and their relation to axonal transport blockage in brains of patients with dementia with Lewy bodies

Katsuse, O., Iseki, E., Marui, W., & Kosaka, K. (2003) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(03)00037-6 · Cited by 98

α-Synuclein in Cerebrospinal Fluid of Alzheimer's Disease and Mild Cognitive Impairment

Korff, A., Liu, C., Ginghina, C., Shi, M., Zhang, J., & Initiative, F. T. A. D. N. (2013) · Journal of Alzheimer’s Disease · doi:10.3233/jad-130458 · Cited by 95

Relationship of phosphorylated α-synuclein and tau accumulation to Aβ deposition in the cerebral cortex of dementia with Lewy bodies

Obi, K., Akiyama, H., Kondo, H., Shimomura, Y., Hasegawa, M., Iwatsubo, T., Mizuno, Y., & Mochizuki, H. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.11.019 · Cited by 93

Co-localization of tau and α-synuclein in the olfactory bulb in Alzheimer’s disease with amygdala Lewy bodies

Fujishiro, H., Tsuboi, Y., Lin, W.-L., Uchikado, H., & Dickson, D. W. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0383-1 · Cited by 93

Lewy-related pathology exhibits two anatomically and genetically distinct progression patterns: a population-based study of Finns aged 85+

Raunio, A., Kaivola, K., Tuimala, J., Kero, M., Oinas, M., Polvikoski, T. M., Paetau, A. E., Tienari, P. J., & Myllykangas, L. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-02071-3 · Cited by 94

Unique α-synuclein pathology within the amygdala in Lewy body dementia: implications for disease initiation and progression

Sorrentino, Z. A., Goodwin, M. S., Riffe, C. J., Dhillon, J.-K. S., Xia, Y., Gorion, K.-M. M., Vijayaraghavan, N., McFarland, K. N., Golbe, L. I., Yachnis, A. T., et al. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0787-2 · Cited by 86

Immunohistochemical comparison of α- and β-synuclein in adult rat central nervous system

Mori, F., Tanji, K., Yoshimoto, M., Takahashi, H., & Wakabayashi, K. (2002) · Brain Research · doi:10.1016/s0006-8993(02)02643-4 · Cited by 84

Alpha-synuclein from patient Lewy bodies exhibits distinct pathological activity that can be propagated in vitro

Marotta, N. P., Ara, J. E., Uemura, N., Lougee, M. G., Meymand, E. S., Zhang, B., Petersson, E. J., Trojanowski, J. Q., & Lee, V. M. ‐. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01288-2 · Cited by 84

Tauopathic Changes in the Striatum of A53T α-Synuclein Mutant Mouse Model of Parkinson's Disease

Wills, J., Credle, J. J., Haggerty, T., Lee, J., Oaks, A. W., & Sidhu, A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017953 · Cited by 79

Morphological substrates of parkinsonism with and without dementia: a retrospective clinico-pathological study

Jellinger, K. A. (2007) · Springer eBooks · doi:10.1007/978-3-211-73574-9_12 · Cited by 77

Pathological entity of dementia with Lewy bodies and its differentiation from Alzheimer?s disease

Marui, W., Iseki, E., Kato, M., Akatsu, H., & Kosaka, K. (2004) · Acta Neuropathologica · doi:10.1007/s00401-004-0869-4 · Cited by 77

Interactions between Tau and α-synuclein augment neurotoxicity in a Drosophila model of Parkinson's disease

Roy, B., & Jackson, G. R. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu011 · Cited by 75

Rapid and Direct Transport of Cell Surface APP to the Lysosome defines a novel selective pathway

Lorenzen, A., Samosh, J., Dewark, K. V., Anborgh, P. H., Seah, C., Magalhães, A. C., Cregan, S. P., Ferguson, S. S. G., & Pasternak, S. (2010) · Molecular Brain · doi:10.1186/1756-6606-3-11 · Cited by 75

Pathology and Neurotransmitter Abnormalities of Dementia with Lewy Bodies

Duda, J. E. (2003) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000074677 · Cited by 73

Amidst an amygdala renaissance in Alzheimer’s disease

Stouffer, K. M., Grande, X., Düzel, E., Johansson, M., Creese, B., Witter, M. P., Miller, M. I., Wisse, L. E. M., & Berron, D. (2023) · Brain · doi:10.1093/brain/awad411 · Cited by 72

Extracellular α-Synuclein Leads to Microtubule Destabilization via GSK-3β-Dependent Tau Phosphorylation in PC12 Cells

Gąssowska-Dobrowolska, M., Czapski, G. A., Pająk, B., Cieślik, M., Lenkiewicz, A. M., & Adamczyk, A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094259 · Cited by 68

The relevance of cerebrospinal fluid α-synuclein levels to sporadic and familial Alzheimer’s disease

for the Dominantly Inherited Alzheimer Network (DIAN), Twohig, D., Rodriguez-Vieitez, E., Sando, S. B., Berge, G., Lauridsen, C., Møller, I., Grøntvedt, G. R., Bråthen, G., Patra, K., et al. (2018) · Acta Neuropathologica Communications · doi:10.1186/s40478-018-0624-z · Cited by 68

APOE4 exacerbates α-synuclein seeding activity and contributes to neurotoxicity in Alzheimer’s disease with Lewy body pathology

Jin, Y., Li, F., Sonoustoun, B., Kondru, N. C., Martens, Y. A., Qiao, W., Heckman, M. G., Ikezu, T. C., Li, Z., Burgess, J. D., et al. (2022) · Acta Neuropathologica · doi:10.1007/s00401-022-02421-8 · Cited by 69

Brain high-throughput multi-omics data reveal molecular heterogeneity in Alzheimer’s disease

Eteleeb, A. M., Novotny, B. C., Tarraga, C. S., Sohn, C., Dhungel, E., Brase, L., Nallapu, A., Buss, J., Farias, F., Bergmann, K., et al. (2024) · PLOS Biology · doi:10.1371/journal.pbio.3002607 · Cited by 64

Interaction between -Synuclein and Other Proteins in Neurodegenerative Disorders

Jellinger, K. A. (2011) · The Scientific World JOURNAL · doi:10.1100/2011/371893 · Cited by 64

Advances in Deep Neuropathological Phenotyping of Alzheimer Disease: Past, Present, and Future

Shakir, M., & Dugger, B. N. (2022) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlab122 · Cited by 58

The complex relationship between soluble and insoluble tau in tauopathies revealed by efficient dephosphorylation and specific antibodies

Hanger, D. P., Gibb, G., de Silva, R., Boutajangout, A., Brion, J., Révész, T., Lees, A. J., & Anderton, B. H. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03611-6 · Cited by 55

Dementia with Lewy bodies: Reclassification of pathological subtypes and boundary with Parkinson's disease or Alzheimer's disease

Iseki, E. (2004) · Neuropathology · doi:10.1111/j.1440-1789.2003.00530.x · Cited by 54

Characteristics of alpha-synucleinopathy in centenarians

Ding, Z., Wang, Y., Jiang, Y., Hashizume, Y., Yoshida, M., Mimuro, M., Inagaki, T., & Iwase, T. (2006) · Acta Neuropathologica · doi:10.1007/s00401-005-0015-y · Cited by 53

Development and validation of an expanded antibody toolset that captures alpha-synuclein pathological diversity in Lewy body diseases

Altay, M. F., Kumar, S. T., Burtscher, J., Jagannath, S., Strand, C., Miki, Y., Parkkinen, L., Holton, J. L., & Lashuel, H. A. (2023) · npj Parkinson s Disease · doi:10.1038/s41531-023-00604-y · Cited by 49

Increased unsaturated lipids underlie lipid peroxidation in synucleinopathy brain

Fu, Y., He, Y. Z., Phan, K., Bhatia, S., Pickford, R., Wu, P., Dzamko, N. L., Halliday, G. M., & Kim, W. S. (2022) · Acta Neuropathologica Communications · doi:10.1186/s40478-022-01469-7 · Cited by 53

Secondary Protein Aggregates in Neurodegenerative Diseases: Almost the Rule Rather than the Exception

Moda, F., Ciullini, A., Dellarole, I. L., Lombardo, A., Campanella, N., Bufano, G., Cazzaniga, F. A., & Giaccone, G. (2023) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2810255 · Cited by 49

Selective reduction of soluble Tau proteins in sporadic and familial frontotemporal dementias: an international follow-up study

Zhukareva, V. A., Sundarraj, S., Mann, D. M. A., Sjögren, M. J. C., Blenow, K., Clark, C. M., McKeel, D. W., Goate, A., Lippa, C. F., Vonsattel, J., et al. (2003) · Acta Neuropathologica · doi:10.1007/s00401-002-0668-8 · Cited by 51

Neuroimmune Tau Mechanisms: Their Role in the Progression of Neuronal Degeneration

Cortés, N., Andrade, V., Guzmán‐Martínez, L., Estrella, M., & Maccioni, R. B. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19040956 · Cited by 43

α-Synuclein: A potent inducer of tau pathology

Geddes, J. W. (2005) · Experimental Neurology · doi:10.1016/j.expneurol.2004.12.002 · Cited by 45

NACP/α-synuclein immunoreactivity in diffuse neurofibrillary tangles with calcification (DNTC)

Yokota, O., Terada, S., Ishizu, H., Tsuchiya, K., Kitamura, Y., Ikeda, K., Uéda, K., & Kuroda, S. (2002) · Acta Neuropathologica · doi:10.1007/s00401-002-0545-5 · Cited by 41

Alzheimer's disease neuropathology and its estimation with fluid and imaging biomarkers

Thal, D. R., Poesen, K., Vandenberghe, R. R., & Meyer, S. D. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00819-y · Cited by 55

NACP/α-Synuclein, NAC, and β-amyloid pathology of familial Alzheimer's disease with the E184D presenilin-1 mutation: a clinicopathological study of two autopsy cases

Yokota, O., Terada, S., Ishizu, H., Ujike, H., Ishihara, T., Nakashima, H., Yasuda, M., Kitamura, Y., Uéda, K., Checler, F., et al. (2002) · Acta Neuropathologica · doi:10.1007/s00401-002-0596-7 · Cited by 42

On the ‘classification’ of neurodegenerative disorders: discrete entities, overlap or continuum?

Armstrong, R. A. (2012) · Folia Neuropathologica · doi:10.5114/fn.2012.30521 · Cited by 41

Occurrence of a-synuclein pathology in the cerebellum of Guamanian patients with parkinsonism-dementia complex

Sebeo, J., Hof, P. R., & Perl, D. P. (2004) · Acta Neuropathologica · doi:10.1007/s00401-004-0840-4 · Cited by 39

Interactions Between α-Synuclein and Tau Protein: Implications to Neurodegenerative Disorders

Li, X., James, S., & Lei, P. (2016) · Journal of Molecular Neuroscience · doi:10.1007/s12031-016-0829-1 · Cited by 39

α-Synuclein, Aβ and Alzheimer's disease

Wirths, O. (2003) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(02)00339-1 · Cited by 37

Region-specific tauopathy and synucleinopathy in brain of the alpha-synuclein overexpressing mouse model of Parkinson's disease

Kaul, T. K., Credle, J. J., Haggerty, T., Oaks, A. W., Masliah, E., & Sidhu, A. (2011) · BMC Neuroscience · doi:10.1186/1471-2202-12-79 · Cited by 37

α-Synuclein seeding amplification assays for diagnosing synucleinopathies: an innovative tool in clinical implementation

Kuang, Y., Mao, H., Huang, X., Chen, M., Dai, W. H., Gan, T., Wang, J., Sun, H., Lin, H., Liu, Q., et al. (2024) · Translational Neurodegeneration · doi:10.1186/s40035-024-00449-2 · Cited by 37

Transcriptional profiling of multiple system atrophy cerebellar tissue highlights differences between the parkinsonian and cerebellar sub-types of the disease

Piras, I. S., Bleul, C., Schrauwen, I., Talboom, J. S., Llaci, L., Both, M. D. D., Naymik, M., Halliday, G. M., Bettencourt, C., Holton, J. L., et al. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-00950-5 · Cited by 37

Heterogeneity of Multiple System Atrophy: An Update

Jellinger, K. A. (2022) · Biomedicines · doi:10.3390/biomedicines10030599 · Cited by 36

Tau Seeding Mouse Models with Patient Brain-Derived Aggregates

Robert, A., Schöll, M., & Vogels, T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22116132 · Cited by 37

Heterotypic interactions in amyloid function and disease

Konstantoulea, K., Louros, N. N., Rousseau, F., & Schymkowitz, J. W. H. (2021) · FEBS Journal · doi:10.1111/febs.15719 · Cited by 34

Lewy‐ and Alzheimer‐type pathologies in midbrain and cerebellum across the Lewy body disorders spectrum

Sierra, M., Gelpí, E., Martı́, M. J., & Compta, Y. (2016) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12308 · Cited by 30

Neuropathology of Parkinson’s Disease

Jellinger, K. A. (2014) · Springer eBooks · doi:10.1007/978-3-319-08046-8_2 · Cited by 31

A microtubule stabilizer ameliorates protein pathogenesis and neurodegeneration in mouse models of repetitive traumatic brain injury

Zhao, X., Zeng, W., Xu, H. W., Sun, Z., Hu, Y., Peng, B., McBride, J. D., Duan, J., Deng, J., Zhang, B., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.abo6889 · Cited by 31

Microglia-driven inflammation induces progressive tauopathies and synucleinopathies

Lee, S. H., Bae, E.-J., Park, S. J., & Lee, S. (2025) · Experimental & Molecular Medicine · doi:10.1038/s12276-025-01450-z · Cited by 31

Mixed pathologies in pancreatic β cells from subjects with neurodegenerative diseases and their interaction with prion protein

Martínez-Valbuena, I., Valenti‐Azcarate, R., Amat, I., Marcilla, I., Martí‐Andrés, G., Caballero, M. C., Riverol, M., Tuñon, M.-T., Fraser, P. E., & Luquín, M. R. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01171-0 · Cited by 30

Dementia with Lewy Bodies and Parkinson's Disease Dementia

Ince, P. G. (2011) · Wiley eBooks · doi:10.1002/9781444341256.ch22 · Cited by 29

Spinal cord involvement in Lewy body-related α-synucleinopathies

Nardone, R., Höller, Y., Brigo, F., Versace, V., Sebastianelli, L., Florea, C., Schwenker, K., Golaszewski, S. M., Saltuari, L. L., & Trinka, E. (2019) · Journal of Spinal Cord Medicine · doi:10.1080/10790268.2018.1557863 · Cited by 28

Alpha-synuclein measured in cerebrospinal fluid from patients with Alzheimer’s disease, mild cognitive impairment, or healthy controls: a two year follow-up study

Berge, G., Sando, S. B., Albrektsen, G., Lauridsen, C., Møller, I., Grøntvedt, G. R., Bråthen, G., & White, L. R. (2016) · BMC Neurology · doi:10.1186/s12883-016-0706-0 · Cited by 29

Controversy: Is Parkinson's disease a single disease entity? Yes

Takahashi, H., & Wakabayashi, K. (2005) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2005.02.011 · Cited by 29

Pick's disease: α- and β-synuclein-immunoreactive Pick bodies in the dentate gyrus

Mori, F., Hayashi, S., Yamagishi, S., Yoshimoto, M., Yagihashi, S., Takahashi, H., & Wakabayashi, K. (2002) · Acta Neuropathologica · doi:10.1007/s00401-002-0578-9 · Cited by 27

Role of tau versus TDP‐43 pathology on medial temporal lobe atrophy in aging and Alzheimer's disease

Wisse, L. E. M., Wuestefeld, A., Murray, M. E., Jagust, W. J., & Joie, R. L. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.14582 · Cited by 24

CSF total tau/α-synuclein ratio improved the diagnostic performance for Alzheimer’s disease as an indicator of tau phosphorylation

Shim, K. H., Kang, M. J., Suh, J. W., Pyun, J., Ryoo, N., Park, Y. H., Youn, Y. C., Jang, J., Jeong, J. H., Park, K. W., et al. (2020) · Alzheimer s Research & Therapy · doi:10.1186/s13195-020-00648-9 · Cited by 28

α-Synuclein Preformed Fibrils Bind to β-Neurexins and Impair β-Neurexin-Mediated Presynaptic Organization

Feller, B., Fallon, A., Luo, W., Nguyen, P. T., Shlaifer, I., Lee, A. K., Chofflet, N., Yi, N., Khaled, H., Karkout, S., et al. (2023) · Cells · doi:10.3390/cells12071083 · Cited by 22

S2–02–04: The status of a–synuclein in Alzheimer cases with and without Lewy bodies

Halliday, G. M. (2006) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2006.05.084

Distinct tau and alpha-synuclein molecular signatures in Alzheimer’s disease with and without Lewy bodies and Parkinson’s disease with dementia

van der Gaag, B., Deshayes, N. A. C., Brevé, J. J. P., Bol, J. G. J. M., Jonker, A. J., Hoozemans, J. J. M., Courade, J., & van de Berg, W. D. J. (2024) · Acta Neuropathologica · doi:10.1007/s00401-023-02657-y · Cited by 45

α‐Synuclein‐positive structures in association with diffuse neurofibrillary tangles with calcification

Hishikawa, N., Hashizume, Y., Ujihira, N., Okada, Y., Yoshida, M., & Sobue, G. (2003) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.2003.00470.x · Cited by 18

Uncovering α-synuclein and tau burden in Alzheimer’s and Lewy body diseases

Quintin, S. S., Paterno, G., Lloyd, G. M., Prokop, S., & Giasson, B. I. (2025) · Brain Communications · doi:10.1093/braincomms/fcaf324 · Cited by 2

Alpha Synuclein co‐pathology is associated with faster Ab‐related tau accumulation in Alzheimer's disease

Roemer, S. N., Dehsarvi, A., Steward, A., Dewenter, A., Pescoller, J., Wagner, F., Levin, J., Brendel, M., Höglinger, G. U., & Franzmeier, N. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.093961 · Cited by 1